Medicare Enrolled

Dr. Zachary Bloomgarden, MD

Optician · New York, NY
Practice pattern: Remote & Electrophysiology — Practice combining remote and electrophysiology services
Consulting-driven
35 E 85TH ST, New York, NY 10028
2128795933
In practice since 2006 (19 years)
NPI: 1700892635 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bloomgarden from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bloomgarden? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bloomgarden

Dr. Zachary Bloomgarden is an optician specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bloomgarden performed 3,105 Medicare services across 1,686 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bloomgarden received a total of $62,395 from 33 pharmaceutical and/or device companies across 184 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bloomgarden is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 25% volume in NY $62,395 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,105
Medicare services
Top 25% in NY for optician
1,686
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~163 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,265 $105 $375
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
456 $30 $250
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
349 $107 $375
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
281 $13 $65
Electrocardiogram, 1-3 leads with physician review
A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician.
280 $8 $10
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
265 $149 $450
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
128 $135 $250
New patient office visit, complex (60-74 min) 48 $177 $500
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
21 $78 $300
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $73 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$62,395
Total received (2018-2024)
Avg $8,914/year across 7 years
Top 5% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
184
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$40,747 (65.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,663 (18.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,985 (16.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,546
2023
$717
2022
$7,342
2021
$508
2020
$3,701
2019
$13,709
2018
$34,872

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$304
Abbott Laboratories
$297
Bayer Healthcare Pharmaceuticals Inc.
$127
Merck Sharp & Dohme LLC
$121
Lilly USA, LLC
$117
Amgen Inc.
$98
Esperion Therapeutics, Inc.
$78
Novartis Pharmaceuticals Corporation
$54
ABBVIE INC.
$52
Corcept Therapeutics
$50
Azurity Pharmaceuticals, Inc.
$42
PFIZER INC.
$32
Janssen Pharmaceuticals, Inc
$30
Insulet Corporation
$28
Boston Scientific Corporation
$26
AstraZeneca Pharmaceuticals LP
$26
Kiniksa Pharmaceuticals International, plc
$26
Novo Nordisk Inc
$21
GlaxoSmithKline, LLC.
$18
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$25,228
Merck Sharp & Dohme Corporation
$7,462
Mannkind Corporation
$6,865
Eli Lilly and Company
$4,725
AstraZeneca UK Limited
$3,245
Amgen Inc.
$3,113
Novo Nordisk Inc
$2,784
Boehringer Ingelheim (China) Investment Co., Ltd.
$2,240
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,676
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,440
Radiometer America, Inc
$672
Abbott Laboratories
$465
Lilly USA, LLC
$375
Esperion Therapeutics, Inc.
$362
AstraZeneca Pharmaceuticals LP
$326
Bayer Healthcare Pharmaceuticals Inc.
$296
Zealand Pharma US, Inc.
$189
Merck Sharp & Dohme LLC
$150
Tandem Diabetes Care, Inc.
$132
Janssen Scientific Affairs, LLC
$104
GlaxoSmithKline, LLC.
$102
Corcept Therapeutics
$100
Novartis Pharmaceuticals Corporation
$54
ABBVIE INC.
$52
Azurity Pharmaceuticals, Inc.
$42
PFIZER INC.
$32
Janssen Pharmaceuticals, Inc
$30
Insulet Corporation
$28
Boston Scientific Corporation
$26
Kiniksa Pharmaceuticals International, plc
$26
AbbVie Inc.
$20
Aegerion Pharmaceuticals, Inc.
$19
Exact Sciences Corporation
$15
Top 3 companies account for 63.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AREXVY · Arcalyst · CREON · CYCLOSET · Cologuard Collection Kit · DIABETES - DISEASE · EDARBI · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · Hb801 · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · MOUNJARO · MYALEPT · NEXLETOL · NEXLIZET · Omnipod · Ozempic · PRALUENT · Prolia · Repatha · STEGLATRO · TOUJEO · TRADJENTA · Tresiba · UBRELVY · VERQUVO · VYNDAMAX · Victoza · WAINUA · WATCHMAN FLX · XARELTO · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (65%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for optician in NY.

Looking for an optician specialist in New York?
Compare opticians in the New York area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
16,073
Per 100K population
987.4
County median income
$104,553
Nearest hospital
LENOX HILL HOSPITAL
0.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bloomgarden is a remote & electrophysiology specialist, with above-average Medicare volume (top 25% in NY), with consulting-driven industry engagement in the top 5% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bloomgarden experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bloomgarden performed 1,265 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bloomgarden receive payments from pharmaceutical companies?
Yes. Dr. Bloomgarden received a total of $62,395 from 33 companies across 184 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bloomgarden's costs compare to other opticians in New York?
Dr. Bloomgarden's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bloomgarden) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →